Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 57 (13%) | |
| Anticipated shortage: | 14 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 366 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
13 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-06-03 | 109425 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-26 | 2020-04-08 | 109432 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2020-03-26 | 2020-04-01 | 109439 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2020-03-26 | 2020-04-03 | 109442 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2020-03-26 | 2020-05-12 | 109445 |
| VALSARTAN | 320MG | TABLET TABLET | Resolved | 2020-05-11 | 2020-08-05 | 114752 |
| VALSARTAN | 40MG | TABLET TABLET | Resolved | 2020-05-11 | 2020-07-09 | 114755 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-11 | 2021-02-10 | 114761 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114766 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
| MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2020-07-08 | 2020-12-11 | 119728 |
| VALSARTAN | 160MG | TABLET TABLET | Resolved | 2020-07-08 | 2021-02-11 | 119741 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2020-07-08 | 2020-10-21 | 119744 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-08 | 2021-02-10 | 119747 |
| CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-20 | 2020-10-30 | 126740 |
| LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2020-10-20 | 2020-11-19 | 126743 |
| MEMANTINE | 10MG | TABLET | Resolved | 2020-10-20 | 2021-02-11 | 126746 |
| FAMOTIDINE | 20MG | TABLET | Resolved | 2020-10-29 | 2024-03-02 | 127488 |
| FAMOTIDINE | 40MG | TABLET | Resolved | 2020-10-29 | 2020-12-11 | 127491 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
| LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-12-17 | 144038 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-08-12 | 144041 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |